Prevention

CDC researchers examine STD services and confidentiality issues among individuals between 15 and 25 years of age and find that not spending time alone with a healthcare provider, without a parent in the room, may limit use of STD services for some youths.

On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers from Rush University presented findings on the efficacy of a new guideline, which aimed to detect whether self-reported beta-lactam allergies were, in essence, unpleasant side-effects to the drugs.

This week’s public health news watch focuses on the President Donald Trump’s nomination of Scott Gottlieb, MD, as the next commissioner of the US Food and Drug Administration.

Studies show that there are about 69 factors that affect gut bacteria directly, including alcohol consumption and chocolate preference

Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.

In late February, the World Health Organization (WHO) released its first list of Priority Pathogens, for which research and development is strongly needed. Not included on the list is tuberculosis, which has been acknowledged as one of the leading killers around the world. Naturally, many individuals working in public health and infectious disease are objecting to the exclusion.

In case you missed them, here is a round-up of the top 5 articles for the week of March 5, 2017.

March 10, 2017 marks the 12th observance of National Women and Girls HIV/AIDS Awareness Day, a day that is dedicated to raising awareness about the impact of HIV/AIDS on women and girls and encouraging them to take action when it comes to preventing infection.

The new WHO list makes a clearcut line-up of offending organisms; however, the list is truly a call to arms for those hoping to prevent the antibiotic apocalypse.

A high-dose flu vaccine may offer more protection to older adults during flu seasons in which Influenza A(N2N3) is circulating.

At the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers presented findings that suggested that a chlamydia vaccine, although costly, can avert significant morbidity.

From pets at home to SeaWorld's main attraction, the threat of antimicrobial resistance in domesticated animals is flying under the radar amid concerns for livestock and human resistance.

Penn State researchers have been granted $2.35 million to go towards finding a way of better predicting infectious disease outbreaks.

The Georgia Department of Public Health reports that the number of HIV infections in Georgia has dropped 6% each year from 2008 to 2014.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, sat down with Contagion™ to discuss antimicrobial susceptibility and resistance and new technologies in the field.

A phase 1 trial is being led by the National Institute of Allergy and Infectious Diseases to evaluate an investigational vaccine designed to provide broad protection against a range of mosquito-transmitted diseases.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University sat down with Contagion™ to discuss up-and-coming prevention methods for C. diff in the hospital setting.

NHL teams are taking extra precautions against mumps, as the highly contagious virus continues its spread from team-to-team in yet another outbreak.

Did you read this week’s top infectious disease news coverage from Contagion®?

More education on the illnesses individuals are risking by refusing vaccines may help to address the issue.

Brown University researchers propose thinking about pre-exposure prophylaxis (PrEP) as a nine-step continuum of preventive care, one that improves uptake and focuses on retention in care.

Catch up on last month's top infectious disease news coverage from Contagion®.

As we await novel compounds from a relatively apathetic industry, we are resurrecting antibiotics of which we have an outdated understanding. and that carry the potential for substantial side effects: polymyxins.

Elimination of viral hepatitis depends on individuals actively participating in their own healthcare and management. They can only do this if they understand why and how to protect their miraculous, life-sustaining liver from harm. Education is the key to prevention.

At the First International Zika Conference, Dr. Bogoch, professor of Emergency Medicine at Boston University School of Medicine, chairman at Replikins LLC, Foundation for Research on the Nervous System, explained how Replikins can give advanced warning of outbreaks and their cessation.

The World Health Organization (WHO) recently published, for the first time, a priority list of antibiotic-resistant bacteria that urgently need new antibiotics.

The results of a new study show that taking antibiotics for traveler’s diarrhea could increase the risk of acquiring an extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL) infection.

The US Food and Drug Administration just announced that it is allowing the marketing of a new test kit for bloodstream infections.

As work with deadly pathogens becomes more advanced, are our biosecurity and biosafety practices regressing?

A survey spanning almost two decades shows a consistent increase in condom-less anal sex and number of sexual partners in MSM as many see antiretroviral therapy as a "protective back-up" measure to avoid HIV infection.